不同糖耐量人群骨质疏松患病率的定量CT评估
本研究在中国平谷开展横断面人群调查,对4001名受试者行口服葡萄糖耐量试验和定量CT(QCT)检测第2至4腰椎体积骨密度(vBMD)。结果显示,QCT评估的骨质疏松患病率在正常糖耐量组为10.6%、糖耐量受损(IGT)组为14.8%、糖尿病(DM)组为16.9%。校正多种代谢因素后,糖化血红蛋白、空腹血糖及餐后血糖与vBMD无关联。
要点
- QCT评估骨质疏松患病率随糖代谢异常程度升高:正常糖耐量10.6%、IGT 14.8%、DM 16.9%
- 年龄与vBMD负相关,体重指数和腰臀比与vBMD正相关
- 校正代谢因素后,糖化血红蛋白、空腹及餐后血糖与vBMD无关联
核心结论
- QCT评估的骨质疏松患病率在正常糖耐量组为10.6%、IGT组为14.8%、DM组为16.9%。
- 校正代谢因素后,糖化血红蛋白、空腹血糖和餐后血糖与vBMD无关联。
研究设计与样本
- 中国平谷开展的横断面人群调查,共纳入4001名符合条件的受试者,平均年龄47.41±11.86岁。
- 受试者接受口服葡萄糖耐量试验,并以QCT测量第2至4腰椎体积骨密度(vBMD)。
主要发现
- QCT评估的骨质疏松患病率:正常糖耐量组10.6%、IGT组14.8%、DM组16.9%。
- 多因素线性回归显示,在所有受试者中年龄与vBMD负相关,体重指数和腰臀比与vBMD正相关。
- 校正性别、年龄、血压、体重指数、血脂、甲状腺功能指标、尿白蛋白肌酐比、肌酐及血尿酸后,糖化血红蛋白、空腹血糖和餐后血糖与vBMD无关联。
临床怎么用
- 在糖代谢异常人群(尤其IGT与DM)中应关注骨质疏松风险,可考虑QCT评估骨密度。
- 评估骨密度时需综合考虑年龄、体重指数和腰臀比等与vBMD相关的因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIM: The objectives of the present study were to compare bone characteristics with quantitative computed tomography (QCT) and other metabolic factors relevant to bone health in subjects with normal glucose tolerance, impaired glucose tolerance (IGT), and diabetes mellitus (DM) and to evaluate the association of various laboratory factors with bone characteristics qualified by QCT. METHODS: This cross-sectional population-based survey of diabetes and metabolic syndrome was conducted in Pinggu, China. The oral glucose tolerance test was conducted and QCT was tested. The volumetric bone mineral density (vBMD) of lumbar vertebrae 2 through 4 was measured. RESULTS: Among the 4001 eligible participants, the average age was 47.41 ± 11.86 years. The prevalence of osteoporosis evaluated by QCT was 10.6% in the normal glucose tolerance group, 14.8% in the IGT group, and 16.9% in the DM group. Multivariate linear regression analysis showed that age was negatively associated with vBMD, whereas body mass index and waist-hip ratio were positively associated with vBMD across all participants. However, the levels of hemoglobin A1c, fasting plasma glucose, and postprandial glucose were not associated with vBMD after adjusting for sex, age, systolic and diastolic blood pressure, body mass index, total cholesterol, triglyceride, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, FT4, FT3, thyroid-stimulating hormone, urine albumin-to-creatinine ratio, creatinine, and serum uric acid. CONCLUSIONS: We found that the prevalence of osteoporosis evaluated by QCT was 10.6% in the normal glucose tolerance group, 14.8% in the IGT group, and 16.9% in the DM group. The levels of hemoglobin A1c, fasting plasma glucose, and postprandial glucose were not associated with vBMD after adjusting for metabolic factors in a Chinese sample.
引用
- Li Y, Zhao Z, Wang L, et al. The Prevalence of Osteoporosis Tested by Quantitative Computed Tomography in Patients With Different Glucose Tolerances. J Clin Endocrinol Metab. 2020. PMID: 31545362. doi:10.1210/clinem/dgz036
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。